We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+7.87%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$9.04B
AUM Growth
+$2.19B
Cap. Flow
+$1.22B
Cap. Flow %
13.44%
Top 10 Hldgs %
34.88%
Holding
3,092
New
1,032
Increased
581
Reduced
587
Closed
820

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$435M
2
AMZN icon
Amazon
AMZN
+$334M
3
MRNA icon
Moderna
MRNA
+$53.9M
4
LIN icon
Linde
LIN
+$44.2M
5
DTE icon
DTE Energy
DTE
+$43.5M

Sector Composition

Rank Sector Weight
1 Miscellaneous 31.51%
2 Technology 15.37%
3 Consumer Discretionary 10.36%
4 Financials 7.14%
5 Industrials 6.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JMIA
1526
Jumia Technologies
JMIA
$881M
$441K ﹤0.01%
+14,533
New +$440K
GDEN
1527
DELISTED
Golden Entertainment
GDEN
$440K ﹤0.01%
+9,818
New +$375K
ALG icon
1528
Alamo Group
ALG
$2B
$439K ﹤0.01%
2,873
+699
+32% +$108K
CMPR icon
1529
Cimpress
CMPR
$2.17B
$439K ﹤0.01%
4,051
-2,401
-37% -$243K
GSQD.U
1530
DELISTED
G Squared Ascend I Inc. Units, each consisting of one Class A ordinary share and one-fifth of one Warrant to acquire one Class A ordinary share
GSQD.U
$439K ﹤0.01%
43,655
OMIC
1531
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$437K ﹤0.01%
+530
New +$411K
ONEW icon
1532
OneWater Marine
ONEW
$194M
$436K ﹤0.01%
+10,372
New +$481K
LCID icon
1533
Lucid Motors
LCID
$2.01B
$432K ﹤0.01%
+1,500
New +$329K
HE icon
1534
Hawaiian Electric Industries
HE
$1.98B
$431K ﹤0.01%
10,198
-14,007
-58% -$607K
INNV icon
1535
InnovAge Holding
INNV
$1.5B
$431K ﹤0.01%
20,209
-17,890
-47% -$409K
FRG
1536
DELISTED
Franchise Group, Inc.
FRG
$431K ﹤0.01%
12,228
-3,694
-23% -$136K
IVAN.U
1537
DELISTED
Ivanhoe Capital Acquisition Corp. Unit, each consisting of one Class A ordinary share and one-third
IVAN.U
$430K ﹤0.01%
40,000
CNO icon
1538
CNO Financial Group
CNO
$5.1B
$428K ﹤0.01%
+18,140
New +$463K
MERC icon
1539
Mercer International
MERC
$26.1M
$426K ﹤0.01%
33,384
-29,116
-47% -$431K
BWA icon
1540
BorgWarner
BWA
$13.2B
$425K ﹤0.01%
+9,945
New +$438K
VOD icon
1541
Vodafone
VOD
$36.7B
$424K ﹤0.01%
+24,738
New +$463K
FSR
1542
DELISTED
Fisker Inc.
FSR
$424K ﹤0.01%
22,010
-21,414
-49% -$316K
SIMO icon
1543
Silicon Motion
SIMO
$8.65B
$423K ﹤0.01%
6,593
-43,720
-87% -$2.87M
PLRX icon
1544
Pliant Therapeutics
PLRX
$71.2M
$422K ﹤0.01%
+14,499
New +$451K
EQBK icon
1545
Equity Bancshares
EQBK
$1.02B
$418K ﹤0.01%
+13,719
New +$420K
MTUS icon
1546
Metallus
MTUS
$825M
$417K ﹤0.01%
29,479
-14,722
-33% -$199K
MDC
1547
DELISTED
M.D.C. Holdings, Inc.
MDC
$417K ﹤0.01%
+8,237
New +$472K
EARN
1548
Ellington Residential Mortgage REIT
EARN
$167M
$416K ﹤0.01%
+35,335
New +$437K
TILE icon
1549
Interface
TILE
$2.19B
$415K ﹤0.01%
+27,118
New +$390K
CNTY icon
1550
Century Casinos
CNTY
$34.6M
$411K ﹤0.01%
+30,623
New +$400K

Similar funds

Michael Gelband's Q2 2021 Portfolio in Review

As of Q2 2021, Michael Gelband held 3,092 positions worth $9.04B, up 32% from $6.86B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Michael Gelband deployed $1.22B of net new capital in Q2 2021, opening 1,032 new positions and adding to 581 existing holdings. Its largest new stake was Linde: 151,692 shares worth $43.9M.

By sector, the portfolio is most concentrated in Miscellaneous at 32% of assets, up from 31% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 1000 Value ETF, an estimated $63.6M trimmed.

  • Michael Gelband's largest Q2 2021 buy was Linde: 151,692 shares worth $43.9M.
  • Michael Gelband added most to Microsoft in Q2 2021, an estimated $435M increase.
  • Michael Gelband's biggest Q2 2021 reduction was iShares Russell 1000 Value ETF, cutting an estimated $63.6M.
  • Michael Gelband fully exited Charles River Laboratories in Q2 2021, selling an estimated $27.9M.
  • Michael Gelband's ten largest holdings make up 35% of its $9.04B portfolio in Q2 2021.
  • Michael Gelband opened 1,032 new positions and closed 820 in Q2 2021.
  • Michael Gelband's portfolio value rose 32% quarter-over-quarter to $9.04B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.